Literature DB >> 11476594

Time course study of GFRalpha-1 expression in an animal model of stroke.

A Sarabi1, C F Chang, Y Wang, B J Hoffer, M Morales.   

Abstract

Previous studies have shown that intracerebral administration of glial cell line-derived neurotrophic factor (GDNF) reduces ischemia-mediated cerebral infarction. The biological effects of GDNF are mediated by GDNF-family receptor alpha-1 (GFRalpha-1) and c-Ret. In this study, we examined the levels of expression of GFRalpha-1 and c-Ret in a rat model of stroke. Adult Sprague-Dawley rats were anesthetized with chloral hydrate. The right middle cerebral artery was ligated at its distal branch for 90 min. Animals were sacrificed at 0, 6, 12, and 24 h after reperfusion and levels of expression of GFRalpha-1 and c-Ret mRNA were determined by in situ hybridization histochemistry. We found that GFRalpha-1 mRNA was up-regulated in CA3, dentate gyrus (DG), cortex, and striatum. The peak of up-regulation in DG was 6 h after reperfusion. GFRalpha-1 mRNA levels in CA3 were gradually up-regulated over the 24-h reperfusion period. In cortex, GFRalpha-1 mRNA was up-regulated at all time points; however, the peak of up-regulation was observed at 0 and 24 h after reperfusion. In striatum, an initial up-regulation of GFRalpha-1 was found at 0 h after ischemia. In striatum, up-regulation of c-Ret mRNA was detected as early as 0 h after reperfusion. A gradual increase was found at 6, 12, and 24 h after reperfusion. In conclusion, our results indicate that there are both regional and temporal differences in up-regulation of GFRalpha-1 and c-Ret after ischemia. Since GDNF is neuroprotective, up-regulation of GFRalpha-1 and c-Ret could enhance the responsiveness to GDNF and reduce neuronal damage. The selective up-regulation of GFRalpha-1 and c-Ret in different brain areas suggests that there may be regional differences in GDNF-induced neuroprotection in stroke. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476594     DOI: 10.1006/exnr.2001.7714

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Distribution of glial cell line-derived neurotrophic factor receptor alpha-1 in the brain of adult zebrafish.

Authors:  Carla Lucini; Lucini Carla; Bruna Facello; Facello Bruna; Lucianna Maruccio; Maruccio Lucianna; Fernanda Langellotto; Langellotto Fernanda; Paolo Sordino; Sordino Paolo; Luciana Castaldo; Castaldo Luciana
Journal:  J Anat       Date:  2010-06-21       Impact factor: 2.610

2.  Effects of cerebral ischemia in mice deficient in Persephin.

Authors:  Andreas C Tomac; Alan D Agulnick; Norman Haughey; Chen-Fu Chang; Yajun Zhang; Cristina Bäckman; Marisela Morales; Mark P Mattson; Yun Wang; Heiner Westphal; Barry J Hoffer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

3.  The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior.

Authors:  Vandana Zaman; Heather A Boger; Ann-Charlotte Granholm; Baerbel Rohrer; Alfred Moore; Mona Buhusi; Greg A Gerhardt; Barry J Hoffer; Lawrence D Middaugh
Journal:  Eur J Neurosci       Date:  2008-10       Impact factor: 3.386

4.  Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice.

Authors:  Yu-Syuan Wang; Tsai-Wei Hung; Eun-Kyung Bae; Kuo-Jen Wu; Wei Hsieh; Seong-Jin Yu
Journal:  CNS Neurosci Ther       Date:  2021-05-21       Impact factor: 5.243

5.  The effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson's disease rat model.

Authors:  Xiaofeng Yin; Huamin Xu; Yunxia Jiang; Wenshuai Deng; Zeyu Wu; Hengwei Xiang; Peng Sun; Junxia Xie
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

6.  Brain ischemia downregulates the neuroprotective GDNF-Ret signaling by a calpain-dependent mechanism in cultured hippocampal neurons.

Authors:  M Curcio; I L Salazar; A R Inácio; E P Duarte; L M T Canzoniero; C B Duarte
Journal:  Cell Death Dis       Date:  2015-02-12       Impact factor: 8.469

7.  Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.

Authors:  William M Pardridge; Ruben J Boado
Journal:  Pharm Res       Date:  2009-07-17       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.